Form 497VPU THRIVENT VARIABLE LIFE
![]() |
Thrivent Variable Universal Life Insurance |
| Thrivent Variable Life Account I | |
| | |
| Updating Summary Prospectus April 30, 2026 |
This updating summary prospectus summarizes key features of a flexible premium individual variable adjustable life insurance
contract (the “Contract”) previously
offered by Thrivent Financial for Lutherans ("Thrivent") between 2004 and 2008.
The prospectus for the Contract contains more information about the Contract, including its features, benefits, and risks. You can find the current prospectus and other information about the
Contract online at
dfinview.com/Thrivent/VariableLife03. You can also obtain this information at no cost by calling
1-800-847-4836, or by sending an email request to [email protected].
Additional general information about certain investment products, including variable life
insurance, has been prepared by the Securities and Exchange Commission’s staff and is available at
Investor.gov.
--------------------------------------------------------------------------------------------------------------------------------------------
The Securities and Exchange Commission has not approved or disapproved this
Contract or passed upon the adequacy of this summary prospectus. Any representation to the contrary is a criminal offense.
Updated Information About Your
Contract
The information in this
Updating Summary Prospectus is a summary of certain Contract features that have changed since the prospectus dated April 30, 2025. This may not reflect all of the changes that have
occurred since you entered into your
Contract.
| Content |
Description of Changes |
| Important Information You Should
Consider About the Contract |
The Annual Portfolio Expenses Table was updated to reflect the new
range. |
| Overview of the Contract |
No changes. |
| Fee Table |
The Fee Table has been updated with the new range of Portfolio Expenses. |
| Premiums |
No changes. |
| Standard Death Benefit |
No changes. |
| Other Benefits |
No changes. |
| Surrenders and Withdrawals |
No changes. |
| Lapse and Reinstatement |
No changes. |
| Availability of Portfolios |
No changes. |
| Other Changes |
The Appendix has been revised to reflect the updated performance information and the current expenses for the Portfolios. |
2
Important Information You Should
Consider About the
Contract
| FEES AND EXPENSES |
Location in
Statutory
Prospectus | |||
| Charges for Early
Withdrawals |
A Decrease Charge (early withdrawal charge) may be assessed upon
surrender, lapse or any decrease in the
Face Amount. A
Decrease Charge will
be assessed for 10 years after each increase in
Face Amount. The
Decrease Charge will vary depending on the number of years since the last increase in
Face Amount
. The maximum amount that may be charged is $49.25 per $1,000 of decrease in Face Amount
. For example, if you make an early withdrawal, you could pay a Decrease
Charge of up to $4,925 on a $100,000 decrease. |
Charges
Fee Table | ||
| Transaction
Charges |
In addition to
Decrease Charges (early withdrawal charges), you also may be
charged for other transactions such as when you pay a premium, transfer
accumulated value between investment options, make more than one
partial surrender in a
Contract Year or exercise your Accelerated Death Benefit Rider.
A premium charge of 5% is deducted upon receipt of most premiums.
A transfer charge applies to each transfer in excess of the first twelve
transfers made in a
Contract Year. The maximum amount deducted is $25 per transfer. You may add an Accelerated Death Benefit Rider to your Contract at any time
without cost. The rider allows you to receive the present value of the death
benefit tax free if eligibility requirements are met, including
doctor certification that the
Insured is terminally ill. A one-time charge of up to $150 will apply if
you exercise the benefit. The charge may be lower in some states.
State variations may apply.
An illustration charge of $25 applies upon each request in excess of one per
|
Charges
Fee Table | ||
| Ongoing Fees and
Expenses (annual
charges) |
In addition to
Decrease Charges (early withdrawal charges) and transaction
charges, investment in the
Contract is subject to certain ongoing fees and
expenses (typically assessed monthly), including fees and expenses covering
the cost of insurance under the
Contract, mortality and expense risk charges,
basic monthly charges, interest on any
Debt, and the cost of optional benefits
available under the
Contract. Some of these fees and expenses are set based
on characteristics of the
Insured (e.g. age, sex (in most states), and rating
classification). See the specifications page of your
Contract for rates
applicable to your
Contract.
Investors will also bear expenses associated with
Portfolios that correspond to
Subaccounts available under the Contract
, as shown in the following table: |
|||
| Annual Fee |
Minimum |
Maximum | ||
| Annual Portfolio Expenses (deducted
from Portfolio assets) |
0.22% |
1.52% | ||
3
| RISKS |
Location in
Statutory
Prospectus | |||
| Risk of Loss |
You can lose money by investing in this
Contract, including loss of your
premiums (principal), and your
Contract can lapse without value.
the amount of premiums considered to meet the
Death Benefit Guarantee Premium requirement. If you surrender the
Contract or allow it to lapse while a
contract loan is outstanding, the amount of
Debt, to the extent it has not
previously been taxed, will be considered part of the amount you receive and
taxed accordingly. Loans may have tax consequences.
|
|||
| Not a Short-Term
Investment |
||||
| Risk Associated
with Investment
Options |
An investment in this
Contract is subject to the risk of poor investment
performance of the investment options you choose.
Each investment option has its own unique risks.
We do not guarantee any money you place in the
Subaccounts. The value of
each Subaccount will increase or decrease, depending on the investment
performance of the corresponding
Portfolio and fees and charges under the
Contract. You could lose some or all of your money. You should review the available Portfolio
s’ prospectuses before making an investment decision. |
|||
| Insurance
Company Risks |
||||
| Contract Lapse |
If your monthly deductions exceed your
Cash Surrender Value, then unless
will enter a 61-day grace period. We will notify you that your
Contract will lapse
(that is, terminate without value) if you do not send us a sufficient payment by
a specified date. No
Death Benefit will be paid if the
Contract is lapsed. We will
reinstate a Contract only if our requirements for reinstatement are satisfied,
which may include requiring new proof of insurability of the
Insured person. |
Lapse and
Reinstatement | ||
4
| RESTRICTIONS |
Location in
Statutory
Prospectus | |||
| Investments |
We place limits on frequent trading. There is a $25 charge for each transfer when you transfer money between investment options in excess of 12 times a year.
Thrivent reserves the right to remove or substitute
Portfolio companies as
investment options that are available under the
Contract.
We reserve the right to not accept any premiums when the
Death Benefit is
based on the
Table of Factors in your
Contract.
We will also have the right to limit or refund a premium payment or make
as life insurance under federal tax law or to avoid the classification of your
Contract
as a “modified endowment contract” (MEC). |
Frequent Trading
Among
Subaccounts and Other
Transactions Addition, Deletion,
Combination or
Substitution of
Investments
Premium Limits
Taxes | ||
| Optional Benefits |
Optional benefits may be subject to age and underwriting requirements. We
generally deduct any monthly costs for these Additional Benefits
from the Accumulated Value as part of the monthly deduction. Optional benefits may
not be available for all ages or underwriting classes, may not be
available after original issue of the
Contract and may terminate at certain ages. We may stop
offering an optional benefit at any time prior to the time you elect to add it to
your Contract. |
|||
| TAXES |
| |||
| Tax Implications |
You should consult with a tax professional to determine the tax implications of
an investment in and payments received under this
Contract. Distributions from your Contract
, if taxable, will be taxed at ordinary income tax rates.
Depending on the total amount of premiums you pay and the frequency of
such payments, the
Contract may be treated as a MEC.
Distributions including loans and loan interest will be taxed on an “income
first” basis and may be subject to a penalty tax if taken
before you are age 59 1∕2 if
your Contract is a MEC. The transfer of the Contract
or designation of a Beneficiary
may have federal, state, and/or local transfer and inheritance tax consequences, including the
impositions of gift, estate, and generation skipping transfer taxes.
|
Taxes | ||
| CONFLICTS OF INTEREST |
Location in
Statutory
Prospectus | |||
| Investment
Professional
Compensation |
We no longer issue this
Contract to new owners. Your financial advisor or
professional may receive compensation which may consist of commissions,
bonuses, asset-based compensation, and promotional incentives. This
conflict of interest may influence your financial advisor or
professional to recommend continued or larger future investments
into this Contract, or another contract issued by Thrivent, over another investment. |
Distribution of the
|
||
| Exchanges |
Some investment professionals may have a financial incentive to offer you a
new contract in place of the one you own. You should only exchange
your contract if you determine, after comparing the features, fees,
and risks of both contracts, that it is better for you to purchase
the new contract rather than continue to own your existing
contract. |
Distribution of the | ||
5
| The total value of the Contract. Accumulated Value equals the sum of the Subaccounts,
the Fixed Account and the Loan Account. | |
| Benefits provided by riders, if any, attached to the Contract. | |
| The person(s) named by the Contract Owner to receive the Death Proceeds under the
Contract. A Beneficiary need not be a natural person. | |
| The Accumulated Value of the Contract less any applicable Decrease Charges and
outstanding loan balances and any deferred monthly
deductions. | |
| The flexible premium variable life insurance Contract offered by us, (Thrivent) and
described in this prospectus. The Contract consists of the Contract, any
additional riders or benefits, amendments, endorsements, the application
and our Articles of Incorporation and Bylaws. |
|
| The same month and day of each year after issue as in the Date of Issue.
| |
| The 12-month period following the Date of Issue or a Contract Anniversary. The
Contract Year is always based upon the time elapsed since the Date of
Issue. | |
| The date when we issue the Contract. This date will be specified in the Contract and
may be different from the Contract Date. The Date of Issue is the date
as of which we begin to apply deductions from your Accumulated
Value. | |
| The amount of the benefit that provides the basis for the Death Proceeds calculation.
The Death Benefit on any day depends on the Death Benefit Option in
effect on that day. | |
| Guarantee |
A Contract provision that guarantees that insurance coverage will not lapse if your
Cash Surrender Value is not adequate to cover the current monthly
deductions as long as premium requirements are met and the
guarantee is in effect. |
| Guarantee Premium |
The minimum monthly premium required to keep the Death Benefit Guarantee(s) in
effect. Different combinations of age, sex, risk class, Face Amount,
Death Benefit Option and Additional Benefits will
result in different Death Benefit Guarantee Premiums.
|
| The amount paid upon the death of the Insured. | |
| All unpaid contract loans plus accrued interest. | |
| A Decrease Charge compensates us for expenses associated with underwriting, issuing
and distributing the Contract. The charge will apply if you increase the
Face Amount and then within 10 years of that increase you decrease the
Face Amount or take a partial surrender that results in a decrease in
Face Amount. We calculate the amount of the Decrease Charge at the time
of the reduction in Face Amount or surrender. The charge is based on the
amount of the increase that is being decreased. We do not deduct this
amount until the next Monthly Anniversary or upon surrender or lapse, if
earlier. | |
| The amount of life insurance for which we issued the Contract. The Face Amount of your
Contract may change, as described in your Contract.
| |
| Fund |
Thrivent Series Fund, Inc., an open-end management investment company, that consists
of several Portfolios that underlie Subaccounts of the Variable
Account. |
| The person on whose life the Contract is issued. | |
| Monthly Anniversary |
The date each month on which we deduct charges from Accumulated Value. These
monthly deductions occur once each month on the Valuation Date, on or
next following the day of the month which corresponds to the day of the
month that we issued the Contract. |
| A person or entity who owns the Contract. | |
| A portfolio of Thrivent Series Fund, Inc. which is the underlying investment of a
corresponding Subaccount which you may select for your Contract. | |
| Our office located at 4321 North Ballard Road, Appleton, Wisconsin 54919-0001 or such
other address as we may designate. Telephone: (800) 847-4836.
Email: [email protected]. | |
| Your available investment options within the Variable Account. Each Subaccount invests
exclusively in the shares of a corresponding Portfolio of the Fund. |
6
| The table found in your Contract and used to help qualify your Contract as a life
insurance contract under federal tax law. |
|
| Valuation Date |
Any day that the New York Stock Exchange is open for regular trading.
|
| Variable Account |
Thrivent Variable Life Account I, which is a separate account of
Thrivent. |
| we, us, our |
Thrivent. |
| you, your |
The Owner(s) of the Contract. |
7
Appendix: Portfolios Available Under the Contract
The following is a list of Portfolios that correspond to subaccounts available under the
Contract. More information about the
Portfolios is available in the prospectuses for the
Portfolios, which may be amended from time to time and can be found online at dfinview.com/Thrivent/VariableLife03.
You can also request this information in paper at no cost by calling (800) 847-4836 or by sending an email request to [email protected].
The current expenses and
performance information below reflects fees and expenses of the Portfolios but does not reflect the other fees and expenses that your Contract may charge. Expenses would be higher and performance would be lower if these charges were included. Each Portfolio’s past performance is not necessarily an indication of future performance.
| INVESTMENT
TYPE |
PORTFOLIO AND ADVISER/SUBADVISER |
CURRENT
EXPENSES |
AVERAGE ANNUAL TOTAL RETURNS
(as of 12/31/25) | ||
| 1 YEAR |
5 YEAR |
10 YEAR | |||
| Aggressive
Allocation |
Thrivent Aggressive Allocation Portfolio |
0.85%1 |
15.81% |
9.61% |
11.26% |
| Large Blend |
Thrivent All Cap Portfolio |
0.66% |
18.05% |
11.90% |
12.43% |
| Conservative
Allocation |
Thrivent Conservative Allocation Portfolio |
0.50% |
10.17% |
4.03% |
5.42% |
| Moderately
Conservative
Allocation |
Thrivent Dynamic Allocation Portfolio |
0.68% |
12.62% |
5.92% |
6.84% |
| Diversified
Emerging
Mkts |
Thrivent Emerging Markets Equity Portfolio |
1.15%1 |
32.20% |
2.10% |
7.47% |
| Large Blend |
Thrivent ESG Index Portfolio |
0.36%1 |
17.78% |
13.56% |
N/A3 |
| Global
Large-Stock
Blend |
Thrivent Global Stock Portfolio |
0.60% |
20.82% |
10.69% |
10.67% |
| Intermediate
Government |
Thrivent Government Bond Portfolio |
0.49% |
7.32% |
0.01% |
1.74% |
| Health |
Thrivent Healthcare Portfolio |
0.92% |
13.07% |
4.62% |
7.37% |
| High Yield
Bond |
Thrivent High Yield Portfolio |
0.45% |
8.78% |
4.06% |
5.32% |
| Corporate
Bond |
Thrivent Income Portfolio |
0.44% |
7.93% |
0.38% |
3.60% |
| Foreign Large
Blend |
Thrivent International Equity Portfolio |
0.72% |
30.87% |
8.54% |
7.41% |
| Foreign Large
Blend |
Thrivent International Index Portfolio |
0.37% |
31.15% |
8.61% |
N/A3
|
| Large Growth |
Thrivent Large Cap Growth Portfolio |
0.43% |
16.95% |
12.89% |
16.35% |
| Large Blend |
Thrivent Large Cap Index Portfolio |
0.22% |
17.62% |
14.17% |
14.54% |
| Large Value |
Thrivent Large Cap Value Portfolio |
0.62% |
19.65% |
13.96% |
12.16% |
| Mid-Cap
Growth |
Thrivent Mid Cap Growth Portfolio |
0.89%1 |
2.50% |
1.10% |
N/A3
|
| Mid-Cap
Blend |
Thrivent Mid Cap Index Portfolio |
0.25% |
7.23% |
8.86% |
10.46% |
| Mid-Cap
Blend |
Thrivent Mid Cap Stock Portfolio |
0.66% |
4.73% |
6.86% |
11.30% |
| Mid-Cap
Value |
Thrivent Mid Cap Value Portfolio |
0.87%1 |
10.82% |
11.31% |
N/A3 |
| Moderate Allocation |
Thrivent Moderate Allocation Portfolio |
0.70%1 |
13.63% |
7.13% |
8.38% |
8
| INVESTMENT
TYPE |
PORTFOLIO AND ADVISER/SUBADVISER |
CURRENT
EXPENSES |
AVERAGE ANNUAL TOTAL
RETURNS
(as of 12/31/25) | ||
| 1 YEAR |
5 YEAR |
10 YEAR | |||
| Moderately
Aggressive
Allocation |
Thrivent Moderately Aggressive Allocation Portfolio
|
0.76%1 |
15.46% |
8.30% |
9.69% |
| Moderately
Conservative
Allocation |
Thrivent Moderately Conservative Allocation
Portfolio |
0.65%1 |
12.10% |
4.49% |
6.04% |
| Money
Market -
Taxable |
Thrivent Money Market Portfolio |
0.31% |
4.06% |
3.05% |
1.93% |
| Multisector
Bond |
Thrivent Multisector Bond Portfolio |
0.74% |
7.93% |
2.43% |
3.47% |
| Real Estate |
Thrivent Real Estate Securities Portfolio |
0.90% |
0.67% |
3.89% |
4.68% |
| Short-Term
Bond |
Thrivent Short-Term Bond Portfolio |
0.45% |
6.06% |
2.75% |
2.89% |
| Small Growth |
Thrivent Small Cap Growth Portfolio |
0.94%1 |
1.87% |
1.37% |
N/A2 |
| Small Blend |
Thrivent Small Cap Index Portfolio |
0.24% |
5.80% |
7.06% |
9.57% |
| Small Blend |
Thrivent Small Cap Stock Portfolio |
0.70% |
2.45% |
7.50% |
11.93% |
1
Current expenses reflect temporary fee reductions.
2
The Fund is not showing Average Annual Total Returns information because the Fund commenced operation on 04/27/2018 and does not have annual returns for the period shown.
3
The Fund is not showing Average Annual Total Returns information because
the Fund commenced operation on 04/29/2020 and does not have annual returns for the period shown.
9
This updating summary prospectus
incorporates by reference the Thrivent flexible premium individual variable adjustable life insurance prospectus and Statement of Additional Information (SAI), both dated April 30,
2026, as amended or supplemented.
The SAI dated April 30, 2026, contains more information about the Contract and Variable
Account. The SAI has been filed with the SEC and is incorporated by reference into the prospectus. The SAI is available, without charge, upon request. You can view a copy of the SAI online at dfinview.com/Thrivent/VariableLife03. For a paper copy of the SAI, to request other information about the Contract, and to make other inquiries, you may call
our Service Center at 1-800-847-4836 or you may send an email to [email protected].
Reports and other information about Thrivent are available on the Securities Exchange Commission website at http://www.sec.gov. Copies of the information may be obtained, upon payment of a duplicating fee, by electronic request at the following email address:
[email protected].
Thrivent is the marketing name for Thrivent Financial for Lutherans.
Insurance products issued by Thrivent. Securities and investment advisory services offered through Thrivent Investment Management Inc., a registered investment adviser, member FINRA and SIPC, and a subsidiary of Thrivent. Licensed agent/producer of Thrivent. Registered representative
of Thrivent Investment Management, Inc. Thrivent.com/disclosures.
Insurance products, securities and investment advisory services are provided by appropriately appointed and licensed financial advisors and professionals. Only individuals who are financial advisors are credentialed to provide
investment advisory services. Visit Thrivent.com or FINRA’s Broker Check for more
information about our financial advisors.
Contract Form V-VQ-VUL(03) and state variations.
EDGAR Contract No. C000007342 21232SPRU R4-26
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Courtly Chinese Porcelain, Rare Himalayan Bronzes and Important Tribal Art Headline Apollo Art Auctions' Fine Asian and Tribal Art Sale
- Allegheny Health Network's Biomarker Moonshot Cancer Research Program Marks Five-Year Milestone, Enrolling More Than 11,000 Patients Across All Cancer Types
- Roche receives FDA approval for the first companion diagnostic to assess PTEN protein in people living with prostate cancer
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share